T1 glottic carcinoma: Do comorbidities, facility characteristics, and sociodemographics explain survival differences across treatment types?

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue 5, 2015, Pages 856-862

  Misono, Stephanie ^a   Marmor, Schelomo ^a,b   Yueh, Bevan ^a   Virnig, Beth A ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

endoscopic laryngeal surgery; glottic cancer; laryngeal cancer; radiation; survival

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; COMORBIDITY; FEMALE; HUMAN; LARYNX CARCINOMA; LARYNX SURGERY; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; ADULT; CHI SQUARE DISTRIBUTION; GLOTTIS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SLEEP APNEA, OBSTRUCTIVE; SMOKING; SURVIVAL;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; SMOKING; SURVIVAL ANALYSIS;

EID: 84930732873     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815572112     Document Type: Article

References (24)

1. Chen AY, Pavluck A, Halpern M, et al. Impact of treating facilities' volume on survival for early-stage laryngeal cancer. Head Neck. 2009 ; 31: 1137-1143
2. Higgins KM, Shah MD, Ogaick MJ, et al. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg. 2009 ; 38: 603-612
3. Misono S, Marmor S, Yueh B, et al. Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis. Cancer. 2014 ; 120: 1810-1817
4. Lassig AA, Joseph AM, Lindgren BR, et al. The effect of treating institution on outcomes in head and neck cancer. Otolaryngol Head Neck Surg. 2012 ; 147: 1083-1092
5. Groome PA, Schulze KM, Keller S, et al. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol). 2006 ; 18: 283-292
6. Zhu J, Fedewa S, Chen AY. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008). Arch Otolaryngol Head Neck Surg. 2012 ; 138: 1120-1128
7. Booth CM, Li G, Zhang-Salomons J, et al. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. 2010 ; 116: 4160-4167
8. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000 ; 110: 593-602
9. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002 ; 40 :
10. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002 ; 40 :
11. Surveillance Epidemiology and End Results (SEER). About SEER. http://seer.cancer.gov/about/. Accessed September 15, 2014.
12. SEER-Medicare Linked Database. 2010 release. http://healthservices.cancer.gov/seermedicare/. Accessed September 15, 2014.
13. Teymoortash A, Werner JA. Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012 ; 11 :
14. National Cancer Institute. Surveillance, Epidemiology and End Results program. Adjustments for areas impacted by Hurricanes Katrina and Rita. http://seer.cancer.gov/data/hurricane.html. Accessed December 24, 2014.
15. Potosky AL, Warren JL, Riedel ER, et al. Measuring complications of cancer treatment using the SEER-Medicare data. Med Care. 2002 ; 40 :
16. Etzioni R, Berry KM, Legler JM, et al. Prostate-specific antigen testing in black and white men: an analysis of Medicare claims from 1991-1998. Urology. 2002 ; 59: 251-255
17. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002 ; 40 :
18. Ragin CC, Langevin SM, Marzouk M, et al. Determinants of head and neck cancer survival by race. Head Neck. 2011 ; 33: 1092-1098
19. Goodwin WJ, Thomas GR, Parker DF, et al. Unequal burden of head and neck cancer in the United States. Head Neck. 2008 ; 30: 358-371
20. Teppo H, Alho OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol. 2009 ; 45: 692-695
21. Vukasinovic M, Djukic V, Stankovic P, et al. Nonvibrating segment predicting glottis carcinoma. Acta Chir Iugosl. 2009 ; 56: 61-64
22. Colden D, Zeitels SM, Hillman RE, et al. Stroboscopic assessment of vocal fold keratosis and glottic cancer. Ann Otol Rhinol Laryngol. 2001 ; 110: 293-298
23. Matsubara N, Umezaki T, Adachi K, et al. Multidimensional voice evaluation in pretreatment glottic carcinoma. Folia Phoniatr Logop. 2005 ; 57: 173-180
24. Surveillance Research Program, National Cancer Institute. Fast stats: an interactive tool for access to SEER cancer statistics. http://seer.cancer.gov/faststats. Accessed September 10, 2014.